Travere Therapeutics TVTX
NASDAQ TVTX
$52.44 -0.14 (-0.27%)
As of: Oct 22, 2026 · 3:59 PM EDT

Travere Therapeutics (TVTX) Long-Term Deferred Tax (2015)

Updated

Travere Therapeutics (TVTX) recorded Long-Term Deferred Tax of $8.69 million in Q2 2015, unchanged from the prior quarter.

Analysis

Travere Therapeutics (TVTX) Long-Term Deferred Tax (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Travere Therapeutics 4.88 Bn 4.48 Bn 167.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 8.69 Mn
Mar 31, 2015 8.69 Mn
API Access

Travere Therapeutics Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=TVTX&period=max&api_key=YOUR_API_KEY